Baxter (BAX) Reports In-Line Q3 EPS; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Baxter Reports Third-Quarter 2022 Results
October 27, 2022 7:15 AM EDTThird-quarter revenue of $3.8 billion increased 17% on a reported basis, 23% on a constant currency basis and rose slightly on an operational basis1 Third-quarter U.S. GAAP earnings (loss) per share (EPS) were ($5.83); Adjusted EPS totaled $0.82 Third-quarter results reflect impairment charges of $3.1 billion related to Baxters December 2021 Hillrom acquisition, primarily reflecting rising interest rates and broad declines in equity valuations
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the third quarter of 2022.
Baxters wide-ranging... More
